Communiqué de presse de Fontaine

ImaBiotech’s first worldwide patent has been granted for its quantification innovation in MSI

Diffusion de communiqué de presse auprès de journalistes qualifiésLille, France – 29th March, 2016 – First worldwide patent has been granted covering ImaBiotech’s research and services platform in the field of Mass spectrometry Imaging (MSI). ImaBiotech, a CRO company developing and offering new imaging technologies, applications, and software, announces today that the company has been granted a patent in USA, France, Australia and China for its lead inno

Lire la suite...

Galderma and ImaBiotech develop a long-term alliance to access Multimaging™ services

Diffusion de communiqué de presse auprès de journalistes qualifiésCommuniqué de presse - Lille, France and Sophia Antipolis, France – November 10th, 2015 –Galderma a leading pharmaceutical company in Dermatology has chosen ImaBiotech to support their drug development with innovative Multimaging™ services.   Galderma has chosen ImaBiotech’s Multimaging™ services to combine and accelerate its drug pharmacokinetic, pharmacology, toxicology and for

Lire la suite...

logo communique presse footer

Suivez-nous !

Suivez sur Twitter afin d'être informé de toutes les actualités.Retrouvez tous les communiqués de presse diffusés et nos actualités sur notre page facebook.Rejoignez sur LinkedInFlux RSS de toutes les catégories de